Balance Labs, Inc.
BLNC
$1.57
$0.000.00%
OTC PK
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 291.43% | -5.66% | |||
| Gross Profit | -291.43% | 5.66% | |||
| SG&A Expenses | -12.92% | 10.92% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 166.20% | 0.63% | |||
| Operating Income | -166.20% | -0.63% | |||
| Income Before Tax | -2,360.44% | -2,182.81% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -2,360.44% | -2,182.81% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -2,360.44% | -2,182.81% | |||
| EBIT | -166.20% | -0.63% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -2,338.81% | -2,133.33% | |||
| Normalized Basic EPS | -2,500.00% | 0.00% | |||
| EPS Diluted | -1,534.00% | -3,233.33% | |||
| Normalized Diluted EPS | -2,500.00% | 0.00% | |||
| Average Basic Shares Outstanding | 1.53% | 0.00% | |||
| Average Diluted Shares Outstanding | 1.53% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||